Literature DB >> 27512478

Antenatal haemoglobinopathy screening: Patterns within a large obstetric service. Working towards a standard of care.

Orly Lavee1, Giselle Kidson-Gerber2.   

Abstract

BACKGROUND: Antenatal screening can predict clinically significant haemoglobinopathies, however in Australia, practices are not standardised and are evolving as the population becomes more ethnically diverse. This study describes antenatal screening practices in a large Australian laboratory/antenatal service.
METHODS: Data were collected retrospectively on consecutive antenatal haemoglobin electrophoresis over 16 months and correlated with obstetric data, obtained from the local obstetric database.
RESULTS: 462 patients were included, with an average gestation of 25.8 weeks. 'Pregnancy' was the most common stated indication, with absent indication/clinical information in 8%. Gestational age was documented in 54%. In 15%, no contact details of the referrer were documented and partner screening was traceable in only 25 cases (5.4%). In 82% of cases, no abnormalities were detected. Beta thalassemia trait was the most common positive result. Only 52% of patients had recent iron studies. The mean haemoglobin was 111.6 g/L and mean cell volume was 80.5 fl at the time of testing. Ethnicity was documented on the request form in 3%. After Australasia, the most common ethnicity of patients was South East Asia and the Middle East.
CONCLUSION: Referral patterns in our health service are diverse and reflect our changing population and care practices. Detailed guidelines are required and we propose a comprehensive algorithm for general use where selective screening is practiced within an Australasian population or one with similar demographics.

Entities:  

Keywords:  Haemoglobinopathies; anaemia; genetic diseases; pregnancy; thalassemia

Year:  2015        PMID: 27512478      PMCID: PMC4935051          DOI: 10.1177/1753495X15598698

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  19 in total

1.  The feasibility of using ethnicity as a primary tool for antenatal selective screening for sickle cell disorders: pointers from the research evidence.

Authors:  Peter J Aspinall; Simon M Dyson; Elizabeth N Anionwu
Journal:  Soc Sci Med       Date:  2003-01       Impact factor: 4.634

2.  Iron deficiency does not compromise the diagnosis of high HbA(2) β thalassemia trait.

Authors:  Cristina Passarello; Antonino Giambona; Monica Cannata; Margherita Vinciguerra; Disma Renda; Aurelio Maggio
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

3.  Antenatal haemoglobinopathy screening.

Authors:  Judy Shakespeare
Journal:  BMJ       Date:  2010-10-18

Review 4.  Thalassaemia screening in pregnancy.

Authors:  Tse N Leung; Tze K Lau; Tony Kh Chung
Journal:  Curr Opin Obstet Gynecol       Date:  2005-04       Impact factor: 1.927

Review 5.  Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls.

Authors:  Barbara J Bain
Journal:  Blood Rev       Date:  2011-05-19       Impact factor: 8.250

6.  Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years.

Authors:  B Modell; M Petrou; M Layton; L Varnavides; C Slater; R H Ward; C Rodeck; K Nicolaides; S Gibbons; A Fitches; J Old
Journal:  BMJ       Date:  1997-09-27

7.  A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy: an alternative approach to electronic blood cell counting.

Authors:  Kanokwan Sanchaisuriya; Supan Fucharoen; Goonnapa Fucharoen; Thawalwong Ratanasiri; Pattara Sanchaisuriya; Yossombat Changtrakul; Uthai Ukosanakarn; Wichai Ussawaphark; Frank P Schelp
Journal:  Am J Clin Pathol       Date:  2005-01       Impact factor: 2.493

8.  Australian Paediatric Surveillance Unit study of haemoglobinopathies in Australian children.

Authors:  Elizabeth Argent; Phillip Emder; Paul Monagle; David Mowat; Toni Petterson; Susan Russell; Rani Sachdev; Christine Stone; David S Ziegler
Journal:  J Paediatr Child Health       Date:  2011-12-13       Impact factor: 1.954

9.  Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.

Authors:  Supatra Sirichotiyakul; Jatuchai Maneerat; Torpong Sa-nguansermsri; Pisawat Dhananjayanonda; Theera Tongsong
Journal:  J Obstet Gynaecol Res       Date:  2005-06       Impact factor: 1.730

Review 10.  Screening and prenatal diagnosis of the haemoglobinopathies.

Authors:  A Cao; M C Rosatelli
Journal:  Baillieres Clin Haematol       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.